These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19766685)

  • 21. Priority setting for risk assessment--the benefit of human experience.
    Alonzo C; Laborde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):692-6. PubMed ID: 16153990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prioritizing industrial chemical hazards.
    Hauschild VD; Bratt GM
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):857-76. PubMed ID: 16020181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling population exposures to outdoor sources of hazardous air pollutants.
    Ozkaynak H; Palma T; Touma JS; Thurman J
    J Expo Sci Environ Epidemiol; 2008 Jan; 18(1):45-58. PubMed ID: 17878926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond risk assessment: principles for assessing community impacts.
    Dunn AJ; Alexeeff GV
    Int J Toxicol; 2010; 29(1):78-87. PubMed ID: 19959838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation of Biomonitoring Equivalents for cyfluthrin.
    Hays SM; Aylward LL; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantitative risk assessment of environmental health hazards: exposure,risk and hazard].
    Szymczak W; Indulski J; Barański B
    Med Pr; 1993; 44(2):169-74. PubMed ID: 8377642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applications.
    Wood M; Pichard A; Gundert-Remy U; de Rooij C; Tissot SM
    J Hazard Mater; 2006 May; 133(1-3):8-15. PubMed ID: 16343752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European union system for the evaluation of substances: the second version.
    Attias L; Boccardi P; Boeije G; Brooke D; de Bruijn J; Comber M; Dolan B; Fischer S; Heinemeyer G; Koch V; Lijzen J; Müller B; Murray-Smith R; Rikken M; Tadeo J; Vermeire T
    Chemosphere; 2005 Apr; 59(4):473-85. PubMed ID: 15788170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dermal Sensitisation Threshold- a TTC approach for allergic contact dermatitis.
    Safford RJ
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):195-200. PubMed ID: 18406502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATSDR evaluation of potential for human exposure to benzene.
    Wilbur S; Wohlers D; Paikoff S; Keith LS; Faroon O
    Toxicol Ind Health; 2008; 24(5-6):399-442. PubMed ID: 19022881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New developments in exposure assessment: the impact on the practice of health risk assessment and epidemiological studies.
    Nieuwenhuijsen M; Paustenbach D; Duarte-Davidson R
    Environ Int; 2006 Dec; 32(8):996-1009. PubMed ID: 16875734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why IRIS is outdated: an additional perspective.
    Graham J
    Risk Anal; 2006 Dec; 26(6):1411-2. PubMed ID: 17184385
    [No Abstract]   [Full Text] [Related]  

  • 35. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment and child health.
    Samet JM
    Pediatrics; 2004 Apr; 113(4 Suppl):952-6. PubMed ID: 15060187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of probabilistic exposure assessment and probabilistic hazard characterization.
    van der Voet H; Slob W
    Risk Anal; 2007 Apr; 27(2):351-71. PubMed ID: 17511703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Policies for chemical hazard and risk priority setting: can persistence, bioaccumulation, toxicity, and quantity information be combined?
    Arnot JA; Mackay D
    Environ Sci Technol; 2008 Jul; 42(13):4648-54. PubMed ID: 18677986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemicals present in automobile traffic tunnels and the possible community health hazards: a review of the literature.
    Kuykendall JR; Shaw SL; Paustenbach D; Fehling K; Kacew S; Kabay V
    Inhal Toxicol; 2009 Aug; 21(9):747-92. PubMed ID: 19555229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ecotoxicological testing: small is reliable.
    Cairns J; McCormick PV; Belanger SE
    J Environ Pathol Toxicol Oncol; 1992; 11(5-6):247-63. PubMed ID: 1464806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.